{"protocolSection":{"identificationModule":{"nctId":"NCT01487746","orgStudyIdInfo":{"id":"0125-11-MMC"},"organization":{"fullName":"Meir Medical Center","class":"OTHER"},"briefTitle":"Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls","officialTitle":"Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy Controls."},"statusModule":{"statusVerifiedDate":"2011-12","overallStatus":"UNKNOWN","lastKnownStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2011-12"},"primaryCompletionDateStruct":{"date":"2012-03","type":"ESTIMATED"},"completionDateStruct":{"date":"2012-09","type":"ESTIMATED"},"studyFirstSubmitDate":"2011-12-05","studyFirstSubmitQcDate":"2011-12-06","studyFirstPostDateStruct":{"date":"2011-12-07","type":"ESTIMATED"},"lastUpdateSubmitDate":"2011-12-06","lastUpdatePostDateStruct":{"date":"2011-12-07","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Meir Medical Center","class":"OTHER"},"collaborators":[{"name":"Sheba Medical Center","class":"OTHER_GOV"}]},"oversightModule":{"oversightHasDmc":false},"descriptionModule":{"briefSummary":"The investigators expect to find higher levels of both classical and minor antiphospholipid (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not only classical APLA but also minor antibodies.\n\nThe investigators believe that minor antibodies have a major role in the hypercoagulability state."},"conditionsModule":{"conditions":["Ischemic Stroke"],"keywords":["APLA","APS","Stroke","minor anti body","major anti body","APLA antibodies in Serum"]},"designModule":{"studyType":"OBSERVATIONAL","designInfo":{"observationalModel":"CASE_CONTROL","timePerspective":"PROSPECTIVE"},"bioSpec":{"retention":"SAMPLES_WITHOUT_DNA","description":"Serum samples of Stroke patients withdrawned within 36 hrs since stroke evoked. Healthy controls"},"enrollmentInfo":{"count":207,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"treatment","description":"Stroke patients"},{"label":"Controls","description":"healthy controls"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* stroke diagnosis\n* blood sampling within 36hrs from the event\n* written agreement\n\nExclusion Criteria:\n\n* a stroke, MI or major operation prior to the current stroke\n* hypercoagulable state known in this patient\n* a severe chronic disease known at the time of the stroke\n* an infection on arrival (based on anamnesis, physical exam and lab tests)\n* thrombolytic treatment","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"on a bank of 207 stroke patients serum samples, and also on 40 healthy controls. The samples were collected during the acute phase of the ischemic event.","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Yair Levy, Prof.","role":"CONTACT","phone":"0533671735","email":"levy.yair@clalit.org.il,"},{"name":"Narin N Carmel, B.Sc","role":"CONTACT","phone":"0547691482","email":"carmeln@gmail.com"}],"locations":[{"facility":"Meir health center","city":"Kfar-saba","country":"Israel","geoPoint":{"lat":32.175,"lon":34.90694}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M3915","name":"Antibodies","relevance":"LOW"},{"id":"M9874","name":"Immunoglobulins","relevance":"LOW"},{"id":"M19151","name":"Antibodies, Antiphospholipid","relevance":"LOW"}],"browseBranches":[{"abbrev":"All","name":"All Drugs and Chemicals"}]}},"hasResults":false}